Search results
Results from the WOW.Com Content Network
Ali R. Rezai (born 1965) [1] is an Iranian-born American neurosurgeon and neuroscientist. [2] [3] His work and research has focused on neuromodulation treatments for patients with neurological and mental health conditions, [4] including neuromodulation techniques such as deep brain stimulation (DBS) through brain chip implants to treat Parkinson's disease tremors, obsessive–compulsive ...
Ohio State University Erica Glasper is an American behavioral neuroscientist. Her laboratory observed the first alterations in hippocampal dendritic morphology and behavioral function induced by social bonding and fatherhood in California mice ( Peromyscus californicus ).
The Semel Institute for Neuroscience and Human Behavior is a research institute of the University of California Los Angeles (UCLA). It includes a number of centers, including the "Center for Neurobehavioral Genetics", which uses DNA sequencing, gene expression studies, bioinformatics, and the genetic manipulation of model organisms to understand brain and behavioral phenotypes.
This microscope photo provided by the McLean Hospital's Harvard Brain Tissue Resource Center in January 2024 shows cells in the caudate nucleus structure of the brain in a person with Huntington's ...
Daniel H. Geschwind is an American physician-scientist whose laboratory has made pioneering discoveries in the biology of brain disorders and the genetic and genomic analyses of the nervous system. His laboratory showed that gene co-expression has a reproducible network structure that can be used to understand neurobiological mechanisms in ...
Since 2009, Jandial is a long-term contributor at KTLA-TV [20] in Los Angeles. In 2019, he became a regular contributor to the TODAY Show in Australia. He hosted Brain Surgery Live on Nat Geo with Bryant Gumbell for international broadcast and was on FOX’s primetime non-scripted Superhuman as a panelist. [ 21 ]
State regulators faulted two hospitals in Southern California for medication errors that put patients at risk, including one who suffered a brain bleed after receiving repeated doses of blood thinner.
[16] [17] As executive chair of the Rockefeller Neuroscience Institute and the John D. Rockefeller IV Chair in neuroscience, Rezai is recognized as a pioneer [18] [19] [20] in neuromodulation technologies to treat Parkinson's disease, obsessive–compulsive disorder, Alzheimer's disease and traumatic brain injury. [16] [21] [22]